Format

Send to

Choose Destination
FEBS Lett. 2005 Jan 31;579(3):699-704.

Selective suppression of Toll-like receptor 4 activation by chemokine receptor 4.

Author information

1
Transplantation Biology, Mayo Clinic, 200 First Street SW, Medical Sciences 2-66, Rochester, MN 55905, USA.

Abstract

The response of Toll-like receptor 4 (TLR4) to lipopolysaccharide (LPS) is thought vital for resisting infection. Since aberrant TLR4 signaling may initiate inflammatory conditions such as the sepsis syndrome, we sought a component of normal cells that might provide local control of TLR4 activation. We found that antibodies that block chemokine receptor 4 (CXCR4) function enhanced TLR4 signaling, while increased expression of CXCR4 or addition of the CXCR4 ligand SDF-1 suppressed TLR4 signaling induced by LPS. These findings suggest that CXCR4 could exert local control of TLR4 and suggest the possibility of new therapeutic approaches to suppression of TLR4 function.

PMID:
15670831
DOI:
10.1016/j.febslet.2004.12.047
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center